Search clinical trials for: SYNERGY XLV (Megatron) Coronary Stent System

Total 136 results

Boston Scientific Corporation

Completed

A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent System

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, Coronary

United States
Jung-min Ahn
CardioVascular Research Foundation, Korea

Recruiting

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent (IRIS SynergyXD)

Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Coronary Disease

Korea, Republic of
Aarhus University Hospital Skejby
Boston Scientific Corporation; Biosensors Europe SA

Unknown

Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII (SORT-OUT VIII)

Coronary Artery Disease | Ischemic Heart Disease

Denmark
University Hospital Heidelberg

Completed

Procedural Advantages of a Novel Drug-Eluting Coronary Stent

Coronary Artery Disease
Boston Scientific Corporation

Completed

SYNERGY China: Assess SYNERGY Stent in China

Cardiovascular Diseases

China
Boston Scientific Corporation

Completed

A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Heart Diseases, Coronary

United States
CCRF Consulting Co., Ltd.
Peking University First Hospital; Terumo Medical(shanghai) Co.,Ltd.

Unknown

Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention

Free Rate of Cardiac or Cerebrovascular Events | Transradial-transfemoral Coronary Interventions Comparison

China
Boston Scientific Corporation

Unknown

A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS™ Element™) for the Treatment of a Single De Novo Coronary Artery Lesion (PLATINUM China)

Coronary Artery Disease | Atherosclerosis

China
Elixir Medical Corporation

Completed

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Coronary Artery Disease

Switzerland, New Zealand, Belgium, Poland, Australia, Brazil, Germany, Netherlands
Conor Medsystems

Terminated

CoStar Catheter System Evaluation (CONCISE)

Symptomatic Ischemic Heart Disease

Germany
CeloNova BioSciences, Inc.
AlpinARC

Completed

Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry (eCOBRA)

Myocardial Infarction | Stable Angina | Unstable Angina | STEMI | NSTEMI - Non-ST Segment Elevation MI | ACS - Acute Coronary Syndrome

France
InspireMD

Completed

The Israeli MGuard Registry

Acute Coronary Syndrome | Ischemic Heart Disease | Acute Myocardial Infarction

Israel
Shanghai Jiao Tong University School of Medicine

Completed

Efficacy and Safety of RESOLUTE Zotarolimus-Eluting Stent in Treatment of Chinese Diabetic Coronary Lesions (RESOLUTE-DM)

Coronary Artery Disease | Diabetes

China
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Medtronic Bakken Research Center

Completed

Assessment of Clinical Performance and Costs of the Endeavor Resolute Stent "in Real Life" in Spain. (REDES)

Coronary Artery Disease

Spain
Atrium Medical Corporation

Terminated

COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1) (CONFIRM 1)

Coronary Artery Disease

Belgium
Abbott Medical Devices

Completed

SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System

Myocardial Ischemia | Coronary Artery Disease | Vascular Disease | Coronary Artery Stenosis | Everolimus

Netherlands, Germany, Denmark
Boston Scientific Corporation

Completed

The OMEGA Clinical Trial

Coronary Artery Disease | Atherosclerosis

Belgium, United States, France, Germany, Latvia, Netherlands, Spain
Methodist Health System

Recruiting

PK Papyrus Covered Coronary Stent System

Coronary Disease

United States
Medinol Ltd.

Completed

BIONICS Israel Trial

Stenosis

Israel
Abbott Medical Devices

Withdrawn

Frontier Registry II Bifurcation Stent System Registry

Coronary Artery Disease
ReFlow Medical, Inc.

Not yet recruiting

A Pilot Study of the Drug-eluting Coronary Spur StEnt as a Primary trEatment for In-stent Restenosis of the CORONARY Arteries (DEEPER CORONARY)

In-stent Restenosis
National Taiwan University Hospital

Unknown

Imaging and Interventional Study for Erectile Dysfunction and Lower Urinary Tract Symptoms (PERFECT)

Lower Urinary Tract Symptoms | Peripheral Arterial Disease | Erectile Dysfunction

Taiwan
B. Braun Melsungen AG

Active, not recruiting

Coroflex ISAR NEO "All Comers" Post Market Clinical Follow-up (PMCF)

Coronary Artery Disease

France
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan
Atrium Medical Corporation

Terminated

The Clinical Evaluation of the Cinatra™ Corolimus-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries (VANTAGE-1)

Coronary Artery Disease

New Zealand
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
Medtronic Vascular

Completed

PROTECT Continued Access Post Marketing Surveillance Trial (PROTECT-CA)

Coronary Artery Disease, Autosomal Dominant, 1

United States
Medtronic Vascular
Medtronic Bakken Research Center

Completed

RESOLUTE International Registry: Evaluation of the Resolute Zotarolimus-Eluting Stent System in a 'Real-World' Patient Population (R-Int)

Cardiovascular Diseases | Coronary Artery Disease

Germany
Biotronik AG

Completed

MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study (MULTIBENE)

Coronary Artery Disease
Fundación EPIC

Recruiting

Coroflex® ISAR NEO PMCF Study (rEPIC07)

Ischemic Heart Disease | Coronary Artery Disease (CAD)

Spain
University Hospital, Toulouse
Boston Scientific Corporation

Completed

Strut Coverage With SYNERGY Stents and Bioresorbable Vascular Scaffold in Acute Myocardial Infarction (COVER-AMI)

Acute Coronary Syndrome

France
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Medtronic Vascular

Completed

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease

China
Meril Life Sciences Pvt. Ltd.

Not yet recruiting

Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions (MeRethonRCT)

Coronary Artery Disease
Spanish Society of Cardiology

Unknown

Reservoir-Based Polymer-Free Amphilimus-Eluting Stent Versus Polymer-Based Everolimus-Eluting Stent in Diabetic Patients (RESERVOIR)

Coronary Artery Disease | Diabetes Mellitus

Spain
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg (DESTINY)

Peripheral Vascular Disease | Critical Limb Ischemia

Belgium, France, Germany
Medinol Ltd.

Not yet recruiting

IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

Coronary Artery Disease | Coronary Stenosis
Medinol Ltd.

Completed

BIONICS Small Vessels Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial

Myocardial Ischemia | Cardiovascular Diseases | Coronary Disease | Coronary Stenosis

Israel
Medinol Ltd.

Completed

BIONICS 38 mm Trial EluNIR Ridaforolimus Eluting Coronary Stent System (EluNIR) In Coronary Stenosis Trial

Coronary Stenosis

Israel
Ceric Sàrl
Boston Scientific Corporation

Completed

Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization. (SENIOR)

Acute Coronary Syndrome | Stable Angina | Silent Myocardial Ischemia

France, Spain, Belgium, Switzerland, United Kingdom, Latvia, Finland, Italy, North Macedonia
Boston Scientific Corporation

Completed

ION US Post-Approval Study

Coronary Artery Disease | Atherosclerosis

United States
Medinol Ltd.

Recruiting

IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN)

Cardiovascular Diseases | Coronary Disease | Non-ST Elevated Myocardial Infarction | Coronary Stenosis

Israel, Brazil
Boston Scientific Corporation

Completed

The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels (PLATINUM SV)

Coronary Artery Disease

United States, Australia, France, Belgium, New Zealand, Japan
Abbott Medical Devices

Completed

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Myocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery Restenosis

United States
Abbott Medical Devices

Completed

SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System (SPIRIT II)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Netherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
Abbott Medical Devices

Completed

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Coronary Artery Disease

United States
Sino Medical Sciences Technology Inc.

Completed

First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

Coronary Artery Disease

Netherlands, Belgium, Spain, Portugal
Abbott Medical Devices

Completed

XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study (XIENCE V India)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

India
Abbott Medical Devices

Completed

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe (SPIRIT V)

Coronary Artery Disease | Coronary Disease | Coronary Restenosis

Ireland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden

Search clinical trials for: SYNERGY XLV (Megatron) Coronary Stent System

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations